BioLattice Ophthalmics, Inc.
PrivateLast Round
Seed
May 5, 2026
Total Funding Raised
$2.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioLattice Ophthalmics, Inc. is a biotechnology company developing engineered cornea solutions as an alternative to donor tissue for transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLattice Ophthalmics, Inc. Comparables
Compare BioLattice Ophthalmics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CorNeat Vision | 85% | |
| LinkoCare Life Sciences | 85% | |
| Precise Bio | 84% |
BioLattice Ophthalmics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 5, 2026 | ||||
| Seed | May 5, 2026 | ||||
| Seed Round | Mar 30, 2026 | ||||
| Grant | Aug 29, 2025 | ||||
| Grant | Aug 29, 2025 | ||||
Pre Seed | Dec 1, 2024 |
BioLattice Ophthalmics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SOSV NY and SOSV SF | Pre Seed |
| Phirst Market Ventures | Pre Seed |
| SOSV | Pre Seed |
| National Science Foundation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 68% MoM.
- Jul 26, 2026
Monthly visitors grew 77% MoM, reaching 1K.
BioLattice Ophthalmics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioLattice Ophthalmics, Inc.'s valuation, stock price, and market status.
Is BioLattice Ophthalmics, Inc. a public or private company?
BioLattice Ophthalmics, Inc. is a private company.
What is the current stock price of BioLattice Ophthalmics, Inc.?
BioLattice Ophthalmics, Inc. is a private company, so its shares have no public market price. Caplight tracks BioLattice Ophthalmics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioLattice Ophthalmics, Inc. worth (valuation)?
Valuation information for BioLattice Ophthalmics, Inc. is not publicly available.
Can I buy BioLattice Ophthalmics, Inc. stock?
BioLattice Ophthalmics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioLattice Ophthalmics, Inc.'s last funding round?
BioLattice Ophthalmics, Inc.'s most recent funding round was Seed on May 5, 2026.
Who are the main investors in BioLattice Ophthalmics, Inc.?
Key investors in BioLattice Ophthalmics, Inc. include SOSV NY and SOSV SF, Phirst Market Ventures, SOSV, National Science Foundation.
Will BioLattice Ophthalmics, Inc. IPO soon?
No public IPO plans have been announced for BioLattice Ophthalmics, Inc..
How can I track BioLattice Ophthalmics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BioLattice Ophthalmics, Inc.'s shares on secondary markets.